Newsroom

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of ENHANCE-3 (NCT07874815), a Phase 3 randomized clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations in adult patients receiving standard of care (SOC) with a history of exacerbations. Recruitment of the ENHANCE-3 trial has begun, and the first patients are now enrolling in the Unite...

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Aptiv PLC (NYSE: APTV) (the “Company”), a global technology company, today announced its third quarter 2026 results via an earnings release available on the Company’s Investor Relations website at https://ir.aptiv.com/financials/quarterly-results/.Management will host an investor conference call to review the results at 8:00 a.m. Eastern Time today. A link to the live webcast and presentation materials will be made available on the Aptiv Investor Relat...

TORONTO--(BUSINESS WIRE)--RPX Gold Inc. (“RPX Gold” or the “Company”) (TSXV: RPX) (OTCQB: RDEXF) is pleased to announce the extension of high-grade gold mineralization with open pit potential originally identified in the 2026 Preliminary Economic Assessment (“PEA”). This extension was determined via its ongoing 2026 drilling program at the Wawa Gold Project (the “Project”) in Ontario, which returned assay results from eleven (11) drill holes totalling 1,845 metres (“m”). The Company continues t...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2026 and raised its full-year 2026 guidance(2) for both Revenues and Adjusted(3) diluted EPS. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "Pfizer had another strong quarter with commercial momentum and disciplined execution while advancing our strategy for creating long-term shareholder value. Our obesity program continued to advance and recent milestones in oncology, i...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Cecile has served as interim Chief Financial Officer since August 16, 2026, steering the company’s financial operations, execution and strategic planning. “Cecile is an exceptional finance leader who knows our company and industry deeply, and she has a proven track record of opt...

PARIS--(BUSINESS WIRE)--Kbrw, spécialiste de l’orchestration et de l’exécution des flux supply chain, et Accenture (NYSE : ACN) ont été choisis par Orange pour transformer la gestion de ses commandes clients et de ses stocks sur ses canaux en ligne, dans ses boutiques et dans ses activités B2B. Ensemble, Kbrw et Accenture accompagnent Orange dans la mise en place d’un processus d’exécution des commandes plus fluide et plus réactif, au bénéfice de ses clients. La première phase du programme de d...

DUBLIN--(BUSINESS WIRE)--Intelligent power management company Eaton Corporation plc (NYSE:ETN) today reported strong third quarter 2026 results, including earnings per share of $2.77. Adjusted earnings per share were a record of $3.68, excluding charges of $0.62 per share related to intangible amortization, $0.30 per share related to acquisitions and divestitures, and income of $0.01 per share related to a multi-year restructuring program. Sales in the quarter were a record $8.9 billion, up 28%...

BOSTON--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced financial results for the second quarter of fiscal 2027 ended September 30, 2026. “Our Q2 results reflect continued top-line growth and strong operational efficiency,” said Rick McConnell, Chief Executive Officer, Dynatrace. “As organizations increasingly deploy AI agents into production, the need for enterprise-grade observability and governance has never been greater. By bringing Ariz...

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEssentia’s blood cancer treatment, ropeginterferon alfa-2b (Ropeg), has secured approvals for essential thrombocythemia (ET) in Taiwan, Japan, the United States, and China, widening treatment options for patients with the chronic disease. In Europe, however, the ET indication remains unapproved, underscoring the gap between clinical advances and patient access across global markets. Developed and manufactured by the Taiwan-based biopharmaceutical company P...

NEW YORK--(BUSINESS WIRE)--Academy Securities, the nation’s first Post-9/11 veteran owned and operated investment bank, today announced the addition of Kathryn Coulter Mitchell to its Geopolitical Intelligence Group. The Academy GIG consists of 45 US and UK Admirals & Generals, former NASA Astronauts, and former CIA/FBI Leadership. Academy has been advising clients for over a decade and is the preeminent Advisory on geostrategic risk to the markets. Kathryn Coulter Mitchell joins Academy af...